Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to reach a profit turning point, with performance exceeding market expectations. The forecast for 2025 indicates a significant recovery in profitability, with a projected net profit of 137.22 million yuan, a year-on-year increase of 124.67% [1][7] - The company anticipates a substantial increase in membrane shipments, with Q4 2025 expected to exceed 35 billion square meters, representing a year-on-year growth of over 70% [7] - The company is actively expanding its product offerings, including lithium sulfide and solid-state electrolyte products, which are positioned to lead in performance metrics within the industry [7] Financial Forecasts - Total revenue is projected to be 13,602 million yuan in 2025, reflecting a year-on-year growth of 33.83% [1] - The net profit attributable to shareholders is forecasted to be 137.22 million yuan in 2025, with significant growth expected in subsequent years, reaching 2,536.42 million yuan in 2026 and 3,149.25 million yuan in 2027 [1][8] - The earnings per share (EPS) is expected to recover to 0.14 yuan in 2025, with further increases to 2.58 yuan in 2026 and 3.21 yuan in 2027 [1][8] Market Data - The closing price of the company's stock is 48.65 yuan, with a market capitalization of approximately 47.79 billion yuan [5] - The company has a price-to-earnings (P/E) ratio of 348.24 for 2025, which is expected to decrease to 18.84 in 2026 and 15.17 in 2027 [1][8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report highlights that the industry is currently at a bottoming phase, awaiting a market clearing, while the company is strategically positioning itself in lithium sulfide to create a second growth curve [1] - The company is expected to see a recovery in its performance, with projected revenue growth in the coming years, particularly in 2025 and 2026 [9] - The report emphasizes the company's strong product performance in lithium sulfide and solid-state electrolyte products, which are leading in key industry metrics [9] Financial Projections - Total revenue is projected to be 12,042 million in 2023, decreasing to 10,164 million in 2024, and then increasing to 11,835 million in 2025, with a growth rate of 16.45% [1] - The net profit attributable to the parent company is expected to recover from a loss of 556.32 million in 2024 to a profit of 208.46 million in 2025, reflecting a year-on-year growth of 137.47% [1] - The earnings per share (EPS) is forecasted to be -0.57 in 2024, improving to 0.22 in 2025, and further increasing to 0.84 in 2026 [1] Market Data - The closing price of the company's stock is 32.07 yuan, with a market capitalization of 31,048.64 million [6] - The company has a price-to-earnings (P/E) ratio of 12.29 for 2023, which is expected to rise to 148.94 in 2025 before decreasing to 38.30 in 2026 [1][10] Operational Insights - The company has seen a significant increase in its membrane shipments, with a total of 46 billion square meters shipped in the first half of 2025, and an expectation to reach 100 billion square meters for the year [9] - The report notes that the company has reduced its capital expenditures significantly, indicating a strategic shift as overseas factories have begun operations [9]